2021 Q1 Form 10-Q Financial Statement
#000143774921011491 Filed on May 10, 2021
Income Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
Revenue | $254.5M | $165.8M |
YoY Change | 53.49% | 17.27% |
Cost Of Revenue | $113.4M | $74.33M |
YoY Change | 52.56% | 17.32% |
Gross Profit | $141.1M | $91.45M |
YoY Change | 54.25% | 17.23% |
Gross Profit Margin | 55.44% | 55.16% |
Selling, General & Admin | $51.45M | $32.16M |
YoY Change | 59.97% | 5.27% |
% of Gross Profit | 36.48% | 35.17% |
Research & Development | $41.89M | $25.96M |
YoY Change | 61.4% | 1.96% |
% of Gross Profit | 29.7% | 28.38% |
Depreciation & Amortization | $5.529M | $4.328M |
YoY Change | 27.75% | 32.96% |
% of Gross Profit | 3.92% | 4.73% |
Operating Expenses | $94.97M | $60.46M |
YoY Change | 57.08% | 7.41% |
Operating Profit | $46.09M | $30.99M |
YoY Change | 48.73% | 42.68% |
Interest Expense | $2.282M | $2.374M |
YoY Change | -3.88% | 39.98% |
% of Operating Profit | 4.95% | 7.66% |
Other Income/Expense, Net | $2.587M | -$1.714M |
YoY Change | -250.93% | -151.3% |
Pretax Income | $48.67M | $29.27M |
YoY Change | 66.28% | 16.82% |
Income Tax | $3.300M | -$6.500M |
% Of Pretax Income | 6.78% | -22.21% |
Net Earnings | $45.41M | $35.76M |
YoY Change | 27.01% | 36.57% |
Net Earnings / Revenue | 17.85% | 21.57% |
Basic Earnings Per Share | $1.00 | $0.80 |
Diluted Earnings Per Share | $0.95 | $0.77 |
COMMON SHARES | ||
Basic Shares Outstanding | 45.50M | 44.46M |
Diluted Shares Outstanding | 47.71M | 46.67M |
Balance Sheet
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $638.8M | $489.3M |
YoY Change | 30.55% | 36.3% |
Cash & Equivalents | $218.4M | $154.9M |
Short-Term Investments | $420.5M | $334.4M |
Other Short-Term Assets | $24.33M | $29.68M |
YoY Change | -18.04% | 117.76% |
Inventory | $175.2M | $131.5M |
Prepaid Expenses | $7.225M | $18.44M |
Receivables | $84.10M | $54.30M |
Other Receivables | $13.50M | $8.300M |
Total Short-Term Assets | $922.4M | $704.8M |
YoY Change | 30.88% | 22.77% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $297.7M | $236.8M |
YoY Change | 25.73% | 15.24% |
Goodwill | $6.571M | $6.571M |
YoY Change | 0.0% | 0.0% |
Intangibles | ||
YoY Change | ||
Long-Term Investments | $3.100M | |
YoY Change | -6.06% | |
Other Assets | $63.78M | $42.46M |
YoY Change | 50.21% | 1.13% |
Total Long-Term Assets | $385.8M | $302.7M |
YoY Change | 27.43% | 10.43% |
TOTAL ASSETS | ||
Total Short-Term Assets | $922.4M | $704.8M |
Total Long-Term Assets | $385.8M | $302.7M |
Total Assets | $1.308B | $1.008B |
YoY Change | 29.84% | 18.78% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $57.24M | $37.75M |
YoY Change | 51.61% | 38.49% |
Accrued Expenses | $74.37M | $56.11M |
YoY Change | 32.54% | 23.73% |
Deferred Revenue | $6.998M | $5.221M |
YoY Change | 34.04% | 78.37% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $187.9M | $112.5M |
YoY Change | 67.04% | 22.84% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $61.64M | $44.22M |
YoY Change | 39.39% | 5.28% |
Total Long-Term Liabilities | $61.64M | $44.22M |
YoY Change | 39.39% | 5.28% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $187.9M | $112.5M |
Total Long-Term Liabilities | $61.64M | $44.22M |
Total Liabilities | $286.6M | $194.3M |
YoY Change | 47.5% | 15.69% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $315.2M | $241.5M |
YoY Change | 30.54% | 19.31% |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $1.022B | $813.2M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $1.308B | $1.008B |
YoY Change | 29.84% | 18.78% |
Cashflow Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $45.41M | $35.76M |
YoY Change | 27.01% | 36.57% |
Depreciation, Depletion And Amortization | $5.529M | $4.328M |
YoY Change | 27.75% | 32.96% |
Cash From Operating Activities | $77.06M | $51.42M |
YoY Change | 49.86% | 32.4% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $18.97M | $9.951M |
YoY Change | 90.63% | -82.95% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$163.9M | -$54.50M |
YoY Change | 200.73% | -290.56% |
Cash From Investing Activities | -$182.9M | -$64.46M |
YoY Change | 183.7% | 109.41% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | $23.47M | $17.43M |
YoY Change | 34.66% | 36.56% |
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -$10.99M | -$4.056M |
YoY Change | 171.03% | 432.98% |
NET CHANGE | ||
Cash From Operating Activities | $77.06M | $51.42M |
Cash From Investing Activities | -$182.9M | -$64.46M |
Cash From Financing Activities | -$10.99M | -$4.056M |
Net Change In Cash | -$116.6M | -$18.08M |
YoY Change | 544.82% | -347.87% |
FREE CASH FLOW | ||
Cash From Operating Activities | $77.06M | $51.42M |
Capital Expenditures | $18.97M | $9.951M |
Free Cash Flow | $58.09M | $41.47M |
YoY Change | 40.08% | -312.22% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
45754000 | |
CY2021Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
45737000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
45737000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
45267000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
45267000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
-124000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
-55000 | USD |
CY2021Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.60 | |
CY2020Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.50 | |
CY2021Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2021Q1 | us-gaap |
Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
|
P5Y | |
CY2021Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | pure |
CY2021Q1 | us-gaap |
Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
|
0 | USD |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
|
0 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
218368000 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
334944000 | USD |
CY2021Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
420455000 | USD |
CY2020Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
260169000 | USD |
CY2021Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
84059000 | USD |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
66843000 | USD |
CY2021Q1 | us-gaap |
Inventory Net
InventoryNet
|
175223000 | USD |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
157062000 | USD |
CY2021Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
24325000 | USD |
CY2020Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
22980000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
45413000 | USD |
CY2021Q1 | us-gaap |
Assets Current
AssetsCurrent
|
922430000 | USD |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
841998000 | USD |
CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
297741000 | USD |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
281528000 | USD |
CY2021Q1 | us-gaap |
Goodwill
Goodwill
|
6571000 | USD |
CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
6571000 | USD |
CY2020Q1 | mpwr |
Litigation Expense Benefit Net
LitigationExpenseBenefitNet
|
2341000 | USD |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
94973000 | USD |
CY2020Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
60461000 | USD |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
46086000 | USD |
CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
30986000 | USD |
CY2021Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2587000 | USD |
CY2021Q1 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
17668000 | USD |
CY2020Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
18556000 | USD |
CY2021Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
63782000 | USD |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
59838000 | USD |
CY2021Q1 | us-gaap |
Assets
Assets
|
1308192000 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
1208491000 | USD |
CY2021Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
57235000 | USD |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
38169000 | USD |
CY2021Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
56307000 | USD |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
45840000 | USD |
CY2021Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
74367000 | USD |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
62960000 | USD |
CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
187909000 | USD |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
146969000 | USD |
CY2021Q1 | us-gaap |
Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
|
37062000 | USD |
CY2020Q4 | us-gaap |
Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
|
37062000 | USD |
CY2021Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
61644000 | USD |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
57873000 | USD |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
286615000 | USD |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
241904000 | USD |
CY2021Q1 | us-gaap |
Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
|
699359000 | USD |
CY2020Q4 | us-gaap |
Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
|
657701000 | USD |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
315206000 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
298746000 | USD |
CY2021Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
7012000 | USD |
CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
10140000 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1021577000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
966587000 | USD |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1308192000 | USD |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1208491000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
254455000 | USD |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
165778000 | USD |
CY2021Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
113396000 | USD |
CY2020Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
74331000 | USD |
CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
141059000 | USD |
CY2020Q1 | us-gaap |
Gross Profit
GrossProfit
|
91447000 | USD |
CY2021Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
41892000 | USD |
CY2020Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
25956000 | USD |
CY2021Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
51453000 | USD |
CY2020Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
32164000 | USD |
CY2021Q1 | mpwr |
Litigation Expense Benefit Net
LitigationExpenseBenefitNet
|
1628000 | USD |
CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1714000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
48673000 | USD |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
29272000 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3260000 | USD |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-6484000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
966587000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
45413000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3128000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35756000 | USD |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.00 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.80 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.95 | |
CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.77 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
45498000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
44455000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
47711000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
46670000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
45413000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35756000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-2474000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-2882000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-654000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-1653000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3128000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-4535000 | USD |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
42285000 | USD |
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
31221000 | USD |
CY2021Q1 | us-gaap |
Dividends
Dividends
|
28953000 | USD |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
10744000 | USD |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
2293000 | USD |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
28621000 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1021577000 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
773491000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35756000 | USD |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-4535000 | USD |
CY2020Q1 | us-gaap |
Dividends
Dividends
|
23741000 | USD |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
11758000 | USD |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1892000 | USD |
CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
18569000 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
813190000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
45413000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35756000 | USD |
CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5529000 | USD |
CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4328000 | USD |
CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-813000 | USD |
CY2020Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-494000 | USD |
CY2021Q1 | mpwr |
Gain Loss On Deferred Compensation Plan Investments Cash Flow
GainLossOnDeferredCompensationPlanInvestmentsCashFlow
|
1177000 | USD |
CY2020Q1 | mpwr |
Gain Loss On Deferred Compensation Plan Investments Cash Flow
GainLossOnDeferredCompensationPlanInvestmentsCashFlow
|
-3750000 | USD |
CY2021Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1004000 | USD |
CY2020Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
3412000 | USD |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
28583000 | USD |
CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
18562000 | USD |
CY2021Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-5000 | USD |
CY2020Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
1000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
17236000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
1635000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
18151000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3994000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
2215000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
10061000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
13513000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
7185000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
10609000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-7374000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
1800000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
34000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
8567000 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
963000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
77057000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
51419000 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
18970000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
9951000 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
201517000 | USD |
CY2020Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
101566000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
38472000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
47397000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
|
25000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
|
100000 | USD |
CY2021Q1 | mpwr |
Contributions Made To Deferred Compensation Plan
ContributionsMadeToDeferredCompensationPlan
|
876000 | USD |
CY2020Q1 | mpwr |
Contributions Made To Deferred Compensation Plan
ContributionsMadeToDeferredCompensationPlan
|
438000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-182866000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-64458000 | USD |
CY2021Q1 | mpwr |
Property And Equipment Purchased On Extended Payment Terms
PropertyAndEquipmentPurchasedOnExtendedPaymentTerms
|
563000 | USD |
CY2020Q1 | mpwr |
Property And Equipment Purchased On Extended Payment Terms
PropertyAndEquipmentPurchasedOnExtendedPaymentTerms
|
279000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
10744000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
11758000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
2293000 | USD |
CY2020Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
1892000 | USD |
CY2021Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
23467000 | USD |
CY2020Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
17427000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-10993000 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4056000 | USD |
CY2021Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
218000 | USD |
CY2020Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-985000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-116584000 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-18080000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
335071000 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
173076000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
218487000 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
154996000 | USD |
CY2021Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
377000 | USD |
CY2020Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
279000 | USD |
CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
12963000 | USD |
CY2020Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
10909000 | USD |
CY2021Q1 | mpwr |
Dividends And Dividend Equivalents Accrued
DividendsAndDividendEquivalentsAccrued
|
29000000 | USD |
CY2020Q1 | mpwr |
Dividends And Dividend Equivalents Accrued
DividendsAndDividendEquivalentsAccrued
|
23725000 | USD |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions used in these condensed consolidated financial statements primarily include those related to revenue recognition, inventory valuation, valuation of share-based awards, contingencies and income tax valuation allowances. Actual results could differ from these estimates and assumptions, and any such differences <em style="font: inherit;"> may </em>be material to the Company’s condensed consolidated financial statements. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">The COVID-<em style="font: inherit;">19</em> pandemic has significantly affected the global economy and is disrupting business operations worldwide for an unknown period of time until the disease is contained. Although these events did <em style="font: inherit;">not</em> adversely affect the Company’s overall operating results and financial condition for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2021</em><i>,</i> they could have a negative impact on the Company’s business operations in future periods. However, the Company is currently unable to predict the size and duration of such impact.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">As of the date of issuance of these condensed consolidated financial statements, the Company is <em style="font: inherit;">not</em> aware of any specific event or circumstance related to the COVID-<em style="font: inherit;">19</em> pandemic that would require management to update the significant estimates and assumptions used in the preparation of the condensed consolidated financial statements, as compared to those disclosed in the Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2020</em><i>.</i> As new events continue to evolve and additional information becomes available, any changes to these estimates and assumptions will be recognized in the condensed consolidated financial statements as soon as they become known.</p> | |
CY2021Q1 | mpwr |
Lapse Period For Consignment
LapsePeriodForConsignment
|
P60D | |
CY2021Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
84100000 | USD |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
66800000 | USD |
CY2021Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
6700000 | USD |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
28583000 | USD |
CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
18562000 | USD |
CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
430000 | USD |
CY2020Q1 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
470000 | USD |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
3105000 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
87.42 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
387000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
353.33 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
460000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
82.43 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
12000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
94.88 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
3020000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
122.26 | |
CY2021Q1 | us-gaap |
Share Price
SharePrice
|
353.21 | |
CY2021Q1 | us-gaap |
Share Price
SharePrice
|
374.57 | |
CY2021Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
26055000 | USD |
CY2020Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
25503000 | USD |
CY2021Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
90571000 | USD |
CY2020Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
77100000 | USD |
CY2021Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
58597000 | USD |
CY2020Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
54459000 | USD |
CY2021Q1 | us-gaap |
Inventory Net
InventoryNet
|
175223000 | USD |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
157062000 | USD |
CY2021Q1 | mpwr |
Tax Withholding Share Based Payment Arrangement Proceeds Receivable
TaxWithholdingShareBasedPaymentArrangementProceedsReceivable
|
11428000 | USD |
CY2020Q4 | mpwr |
Tax Withholding Share Based Payment Arrangement Proceeds Receivable
TaxWithholdingShareBasedPaymentArrangementProceedsReceivable
|
12504000 | USD |
CY2021Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
7225000 | USD |
CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
5032000 | USD |
CY2021Q1 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
2126000 | USD |
CY2020Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
1914000 | USD |
CY2021Q1 | mpwr |
Product Return Assets Current
ProductReturnAssetsCurrent
|
1724000 | USD |
CY2020Q4 | mpwr |
Product Return Assets Current
ProductReturnAssetsCurrent
|
1684000 | USD |
CY2021Q1 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
1822000 | USD |
CY2020Q4 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
1846000 | USD |
CY2021Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
24325000 | USD |
CY2020Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
22980000 | USD |
CY2021Q1 | us-gaap |
Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
|
48138000 | USD |
CY2020Q4 | us-gaap |
Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
|
46146000 | USD |
CY2021Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
5845000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
3719000 | USD |
CY2021Q1 | us-gaap |
Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
|
2503000 | USD |
CY2020Q4 | us-gaap |
Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
|
2340000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
2820000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
2861000 | USD |
CY2021Q1 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
3180000 | USD |
CY2020Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
3400000 | USD |
CY2021Q1 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
1296000 | USD |
CY2020Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
1372000 | USD |
CY2021Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
63782000 | USD |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
59838000 | USD |
CY2021Q1 | mpwr |
Dividends And Dividend Equivalents
DividendsAndDividendEquivalents
|
31472000 | USD |
CY2020Q4 | mpwr |
Dividends And Dividend Equivalents
DividendsAndDividendEquivalents
|
26435000 | USD |
CY2021Q1 | mpwr |
Stock Rotation Reserve And Accrued Sales Returns
StockRotationReserveAndAccruedSalesReturns
|
6240000 | USD |
CY2020Q4 | mpwr |
Stock Rotation Reserve And Accrued Sales Returns
StockRotationReserveAndAccruedSalesReturns
|
6005000 | USD |
CY2021Q1 | mpwr |
Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
|
5339000 | USD |
CY2020Q4 | mpwr |
Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
|
5841000 | USD |
CY2021Q1 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
5545000 | USD |
CY2020Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
3755000 | USD |
CY2021Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
6998000 | USD |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
7238000 | USD |
CY2021Q1 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
1252000 | USD |
CY2020Q4 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
1107000 | USD |
CY2021Q1 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
9941000 | USD |
CY2020Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
6895000 | USD |
CY2021Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
5627000 | USD |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
4278000 | USD |
CY2021Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
74367000 | USD |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
62960000 | USD |
CY2021Q1 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
49837000 | USD |
CY2020Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
48280000 | USD |
CY2021Q1 | mpwr |
Dividend Equivalents Noncurrent
DividendEquivalentsNoncurrent
|
8323000 | USD |
CY2020Q4 | mpwr |
Dividend Equivalents Noncurrent
DividendEquivalentsNoncurrent
|
7871000 | USD |
CY2021Q1 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
30000 | USD |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
29000 | USD |
CY2021Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
61644000 | USD |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
57873000 | USD |
CY2021Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
499000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
366000 | USD |
CY2021Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
121000 | USD |
CY2020Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
77000 | USD |
CY2021Q1 | us-gaap |
Lease Cost
LeaseCost
|
620000 | USD |
CY2020Q1 | us-gaap |
Lease Cost
LeaseCost
|
443000 | USD |
CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
312000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
373000 | USD |
CY2021Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
2940000 | USD |
CY2020Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
277000 | USD |
CY2021Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y7M6D | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y8M12D | |
CY2021Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.023 | pure |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.027 | pure |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1602000 | USD |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
1582000 | USD |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
1015000 | USD |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
829000 | USD |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
637000 | USD |
CY2021Q1 | mpwr |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
8000 | USD |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
5673000 | USD |
CY2021Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
266000 | USD |
CY2021Q1 | mpwr |
Lessee Operating Lease Lease Not Yet Commenced Future Lease Obligations
LesseeOperatingLeaseLeaseNotYetCommencedFutureLeaseObligations
|
4000000.0 | USD |
CY2021Q1 | us-gaap |
Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
|
300000 | USD |
CY2020Q1 | us-gaap |
Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
|
400000 | USD |
CY2021Q1 | us-gaap |
Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
|
1691000 | USD |
CY2021Q1 | us-gaap |
Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
|
2241000 | USD |
CY2021Q1 | us-gaap |
Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
|
1568000 | USD |
CY2021Q1 | us-gaap |
Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
|
581000 | USD |
CY2021Q1 | us-gaap |
Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
|
59000 | USD |
CY2021Q1 | us-gaap |
Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
|
6140000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
45413000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35756000 | USD |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
45498000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
44455000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
2213000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
2215000 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
47711000 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
46670000 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.00 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.80 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.95 | |
CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.77 | |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
254455000 | USD |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
165778000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
254455000 | USD |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
165778000 | USD |
CY2021Q1 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
297741000 | USD |
CY2020Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
281528000 | USD |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
6895000 | USD |
CY2019Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1139000 | USD |
CY2021Q1 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
3609000 | USD |
CY2020Q1 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
541000 | USD |
CY2021Q1 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
313000 | USD |
CY2020Q1 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
111000 | USD |
CY2021Q1 | us-gaap |
Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
|
250000 | USD |
CY2020Q1 | us-gaap |
Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
|
425000 | USD |
CY2021Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
9941000 | USD |
CY2020Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1144000 | USD |
CY2021Q1 | us-gaap |
Purchase Obligation
PurchaseObligation
|
152200000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
2179000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
258000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
297365000 | USD |
CY2021Q1 | us-gaap |
Cash
Cash
|
197744000 | USD |
CY2020Q4 | us-gaap |
Cash
Cash
|
300609000 | USD |
CY2021Q1 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
20624000 | USD |
CY2020Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
34335000 | USD |
CY2021Q1 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
106763000 | USD |
CY2020Q4 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
0 | USD |
CY2021Q1 | us-gaap |
Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
|
0 | USD |
CY2020Q4 | us-gaap |
Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
|
2999000 | USD |
CY2021Q1 | us-gaap |
Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
|
7491000 | USD |
CY2020Q4 | us-gaap |
Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
|
7499000 | USD |
CY2021Q1 | mpwr |
Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
|
641643000 | USD |
CY2020Q4 | mpwr |
Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
|
597974000 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
218368000 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
334944000 | USD |
CY2021Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
420455000 | USD |
CY2020Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
260169000 | USD |
CY2021Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
2820000 | USD |
CY2020Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
2861000 | USD |
CY2021Q1 | mpwr |
Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
|
641643000 | USD |
CY2020Q4 | mpwr |
Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
|
597974000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
89085000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
89289000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
330053000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
331166000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
2995000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
2820000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
|
422133000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
|
423275000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
442757000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
1611000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
469000 | USD |
CY2021Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
443899000 | USD |
CY2020Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
295444000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
160362000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
294000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
2820000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
175000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
163182000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
469000 | USD |
CY2020Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
65142000 | USD |
CY2020Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
99000 | USD |
CY2020Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
2861000 | USD |
CY2020Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
159000 | USD |
CY2020Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
68003000 | USD |
CY2020Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
258000 | USD |
CY2021Q1 | mpwr |
Redemption Auction Rate Securities To Date
RedemptionAuctionRateSecuritiesToDate
|
40300000 | USD |
CY2021Q1 | mpwr |
Percentage Of Auction Rate Securities Redeemedat Par Value
PercentageOfAuctionRateSecuritiesRedeemedatParValue
|
0.93 | pure |
CY2021Q1 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
3200000 | USD |
CY2020Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
3400000 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
218368000 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
334944000 | USD |
CY2021Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
119000 | USD |
CY2020Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
127000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
218487000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
335071000 | USD |
CY2021Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
472151000 | USD |
CY2020Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
324289000 | USD |
CY2021Q1 | us-gaap |
Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
|
48138000 | USD |
CY2020Q4 | us-gaap |
Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
|
46146000 | USD |
CY2021Q1 | us-gaap |
Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
|
50233000 | USD |
CY2020Q4 | us-gaap |
Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
|
48435000 | USD |
CY2021Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
2282000 | USD |
CY2020Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
2374000 | USD |
CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-813000 | USD |
CY2020Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-494000 | USD |
CY2021Q1 | mpwr |
Gain Loss On Deferred Compensation Plan Investments
GainLossOnDeferredCompensationPlanInvestments
|
1177000 | USD |
CY2020Q1 | mpwr |
Gain Loss On Deferred Compensation Plan Investments
GainLossOnDeferredCompensationPlanInvestments
|
-3750000 | USD |
CY2021Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
15000 | USD |
CY2020Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
3000 | USD |
CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-74000 | USD |
CY2020Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
153000 | USD |
CY2021Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2587000 | USD |
CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1714000 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3300000 | USD |
CY2021Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.067 | pure |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-6500000 | USD |
CY2020Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.222 | pure |
CY2021Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.60 | |
CY2020Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.50 | |
CY2021Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
27393000 | USD |
CY2020Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
22317000 | USD |
CY2021Q1 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
27400000 | USD |
CY2020Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
22600000 | USD |
CY2021Q1 | mpwr |
Accrued Dividend Equivalents
AccruedDividendEquivalents
|
12400000 | USD |
CY2020Q4 | mpwr |
Accrued Dividend Equivalents
AccruedDividendEquivalents
|
11700000 | USD |